The recurrence and survival of oral squamous cell carcinoma: A report of 275 cases

Chinese Journal of Cancer

Volumn 32, Issue 11, 2013, Pages 614-618

  Wang, Bo ^a   Zhang, Shu ^a   Yue, Kai ^a   Wang, Xu Dong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Oral tumors; Recurrence; Squamous cell carcinoma; Survival

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; NECK DISSECTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; QUALITY OF LIFE; RADIATION DOSE; RECURRENCE FREE SURVIVAL; SEX DIFFERENCE; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TAXOIDS; YOUNG ADULT;

EID: 84887327347     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.012.10219     Document Type: Article

References (11)

1. Bagan JV, Scully C. Recent advances in oral oncology 2007: epidemiology, aetiopathogenesis, diagnosis and prognostication. Oral Oncol, 2008,44:103-108.
2. Camisasca DR, Silami MA, Honorato J, et al. Oral squamous cell carcinoma clinicopathological features in patients with and without recurrence. ORL J Otorhinolaryngol Relat Spec, 2011,73:170-176.
3. Lindenblatt Rde C, Martinez GL, Silva LE, et al. Oral squamous cell carcinoma grading systems--analysis of the best survival predictor. J Oral Pathol Med, 2012,41:34-39.
4. Ebrahimi A, Clark JR, Zhang WJ, et al. Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma. Head Neck, 2011,33:1245-1251.
5. Vázquez-Mahía I, Seoane J, Varela-Centelles P, et al. Predictors for tumor recurrence after primary definitive surgery for oral cancer. J Oral Maxillofac Surg, 2011,70:1724-1732.
6. de Vicente JC, Rodríguez-Santamarta T, Rosado P, et al. Survival after free flap reconstruction in patients with advanced oral squamous cell carcinoma. J Oral Maxillofac Surg, 2012,70:453-459.
7. Capote A, Escorial V, Rodri{dotless}́guez-Campo FJ, et al. Elective neck dissection in early-stage oral squamous cell carcinoma-dose it influence recurrence and survival? Head Neck, 2007,29:3-11.
8. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med, 2004,350:1937-1944.
9. López Rodríguez M, Cerezo Padellano L, Martín Martín M, et al. Neck dissection after radiochemotherapy in patients with locoregionally advanced head and neck cancer. Clin Transl Oncol, 2008,10:812-816.
10. Cheng SJ, Lee JJ, Cheng SL, et al. Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma. Oral Oncol, 2012,48:424-428.
11. Liu LK, Jiang XY, Zhou XX, et al. Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod Pathol, 2010,23:213-224.